Drug recall · June 19, 2024
Docetaxel Injection recall
Why: Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08
- Lots / codes
Lot #: F1030001, Exp. Date 12/31/2024
- Quantity
- 2806 vials
- Company
- Sagent Pharmaceuticals, Schaumburg, IL
- Distribution
- Nationwide within the USA.
- Initiated
- May 28, 2024 · Voluntary: Firm initiated
- Classified
- June 12, 2024
- Reported
- June 19, 2024
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Docetaxel
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.